Legislation
Latest News
May 19, 2026 – Today, senior advocacy group RetireSafe released the following statement urging Congress to reject Most Favored Nation (MFN) codification proposals.
“RetireSafe strongly urges members of Congress to reject proposals to codify Most Favored Nation (MFN) pricing policy in reconciliation legislation. MFN would index American pharmaceutical prices to those in countries with socialized healthcare systems that use discriminatory valuation tools like the quality-adjusted life year (QALY)—which puts older patients’ care needs at the back of the line. Seniors, who are often on fixed incomes and rely on Medicare for coverage, depend on affordable access to a variety of medications to treat diseases or improve their quality of life. MFN risks all of that access for the patients who can least afford care disruptions.
“Despite promises that MFN will lower costs, MFN would deny senior access to the treatments they depend on. Lawmakers who want to stand up for America’s seniors should reject MFN amendments during the reconciliation process.”
April 17, 2026 – Today, RetireSafe released the following statement on the recent Senate HELP Committee hearing, “Making Medicines More Affordable: How Competition Can Lower Drug Prices.”
“RetireSafe, an advocacy organization dedicated to promoting the interests of America’s seniors, was pleased to see members of Congress discussing ways to improve healthcare affordability in the recent Senate HELP Committee hearing on the issue. In particular, our organization applauds the Committee’s criticism of pharmacy benefits manager (PBM) practices, which have, for far too long, driven up Medicare Part D list prices and allowed big insurance conglomerates to profit from seniors’ losses.
“At the same time, RetireSafe was disappointed by lawmaker support for price control measures—like Most Favored Nation (MFN) policies and proposed expansion of the Inflation Reduction Act (IRA) Medicare Drug Price “Negotiation” Program—that will hurt innovation and limit senior access to existing and future treatments. A lack of focus on the 340B program, which is often abused by participating hospitals to pocket patient savings, was also disheartening. RetireSafe urges Washington to pursue continued insurer and PBM reforms and legislation to prevent participating hospitals from taking advantage of the 340B program to improve health affordability without sacrificing access.”
December 10, 2025 – Today, RetireSafe released the following statement applauding the recent introduction of the Pharmacy Benefit Manager (PBM) Price Transparency and Accountability Act in the United States Senate Finance Committee:
“Senior advocacy organization RetireSafe commends members of the Senate Finance Committee for recently introducing bipartisan PBM reform legislation. Currently, PBMs overcharge patients and promote high-priced medications, increasing out-of-pocket costs in order to boost their profits. If passed, the Pharmacy Benefit Manager (PBM) Price Transparency and Accountability Act will take the steps needed to stop these bad actors from driving up drug prices for seniors in need.
“The legislation would specifically increase PBM reporting requirements to Medicare Part D plan sponsors and allow these sponsors to audit their PBMs for compliance within contracts. This will help ensure that seniors, in particular, are protected from the opaque, cost-increasing practices of drug middlemen. Many seniors take multiple medications to treat various conditions and maintain their overall quality of life, and they rely on consistent, affordable access to these drugs. Members of Congress who want to protect senior patients should be swift to support this PBM reform legislation to ensure that every senior can access the treatments they need.”
November 19, 2025 – Today, RetireSafe composed and organized a sign-on letter to Congress in support of the RESULTS Act:
RetireSafe and many other organizations have co-signed a letter to Senate Majority Leader John Thune, Senate Minority Leader Charles Schumer, Speaker of the House Mike Johnson, and House Minority Leader Hakeem Jeffries in strong support of the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. This act aims to help ensure that medical laboratory tests remain accurate, accessible, and affordable for the many senior Americans that rely on them.
Click here to read the full letter.
May 20, 2025 – Today, RetireSafe released the following statement expressing opposition to President Trump’s executive order implementing the “most favored nation” (MFN) policy in Medicare:
“The senior advocacy organization RetireSafe stands opposed to President Trump’s new executive order implementing the “most favored nation” (MFN) policy into Medicare. As an organization that fights on behalf of the Medicare beneficiaries that this policy will most impact, we can confidently state that this policy will harm America’s seniors far more than help them. By giving other nations the power to effectively control Medicare prices, MFN will decrease access to treatments seniors rely upon. Furthermore, altering the Medicare market could have unintended or unforeseen side effects on senior treatments more broadly, as well as premium costs, and mirroring smaller socialized healthcare markets would only upend a working program and cause larger cost issues in the long term.
“However, the impacts of the implementation of this devastating policy will extend beyond Medicare beneficiaries. Drugmakers writ large may choose to pull back on investing in new developments as they fear a price set by foreign governments will inhibit their ability to recoup returns on their investment. RetireSafe urges the Administration to reconsider utilizing MFN in Medicare to protect seniors and their access to treatments that allow them to live long, fulfilling lives.”
Washington, DC (November 12, 2024) – RetireSafe issued the following statement regarding the election of Donald Trump as the next President of the United States of America.
“We extend our congratulations to the newly-elected President of the United States, Donald Trump. Moving forward, RetireSafe is eager to work with his Administration to promote healthcare policies that will protect America’s aging population. Although we have reached the end of a tough election season, the real work lies ahead as we pursue a pro-patient agenda that will better the lives of our nation’s seniors. This includes protecting and strengthening Medicare and addressing policies that disrupt and worsen seniors’ access to high-quality healthcare.
RetireSafe urges President-elect Trump to work alongside the new Congress to enact legislation that ensures access to essential medications. Seniors, many of whom are on fixed incomes and require multiple medications to treat various conditions, need leaders who will champion their healthcare needs and concerns. This includes protecting and preserving Social Security and Medicare, which allow them to access their much-needed medications.”
Outreach and Advocation
A core pillar of RetireSafe’s mission is “advocating for YOU!”
One way we put that into practice is by sending letters directly to government officials — urging action or offering commentary on key issues. Below, you’ll find letters straight from the President and CEO’s desk, addressing recent policies and decisions that impact the rights and well-being of American seniors.
More Letters
Current Bills
H.R.4619: Medicare Mental Health Inpatient Equity Act of 2025
This bill removes the 190-day lifetime limit on inpatient psychiatric hospital services under Medicare.
H.R.4967: Keep Seniors Fed Act
This bill amends the Supplemental Nutrition Assistance Program (SNAP) to exempt certain Social Security benefits (e.g., retirement and disability benefits) from household income for the purposes of determining program eligibility.
H.R.5269: Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act
This bill reforms how Medicare sets laboratory test payment rates to use more representative data, reduce reporting burdens, and prevent steep cuts that could limit seniors’ access to essential lab services.
H.R.6160: Amendment to Title XVIII of the Social Security Act
This bill requires Medicare Advantage plans to track and report how often prior authorization denials are later overturned. The goal is to increase oversight and reduce wrongful delays or denials of care for patients
S.2617: Reducing Drug Prices for Seniors Act
This bill requires the coinsurance amount for covered drugs under the Medicare prescription drug benefit to be based on the net price of the drug (i.e., the negotiated price under the prescription drug plan net of any manufacturer price concessions), rather than the list price of the drug, if the net price is lower.
S.2770: Share the Savings with Seniors Act
This bill limits cost-sharing for chronic care drugs under the Medicare prescription drug benefit. Chronic care drugs include blood glucose regulators other than insulin, anticoagulants, and other categories of drugs as specified in the bill.
H.R.3514/S.1816: Improving Seniors’ Timely Access to Care Act of 2025
This bill would require Medicare Advantage plans to improve transparency and oversight of their use of prior authorization, including reporting data on denials and appeals. The goal is to reduce unnecessary delays in care and ensure beneficiaries are not improperly denied medically needed services.
H.R.8344/S.4184: Senior Citizens’ Freedom to Work Act of 2026
Amends the Social Security Act to eliminate the retirement earnings test, meaning seniors could work and earn income without having their Social Security benefits reduced.
H.R.4313/S.2237: Hospital Inpatient Services Modernization Act
This bill extends the Acute Hospital Care at Home Program under Medicare and requires an additional study regarding the program. The program allows hospitals to treat certain patients from emergency departments or inpatient hospital beds at home.
H.R.6160: Strengthening Medicare for Patients and Providers Act
This bill modifies certain adjustments to payment amounts
under the Medicare physician fee schedule.
H.R.5454: Medicare Advantage Prompt Pay Act
This bill would require Medicare Advantage plans to follow faster and more consistent payment timelines when paying claims to healthcare providers. The goal is to ensure providers are paid more promptly and reduce delays in reimbursement.
H.R.4559: Prompt and Fair Pay Act
This bill would increase oversight of Medicare Advantage plans by strengthening federal review of their marketing practices and coverage decisions. It aims to improve transparency and protect beneficiaries from misleading plan information and inappropriate coverage denials.
H.R.6031: Medicare Advantage Integrity Act of 2025
This bill temporarily establishes geographic adjustments for certain Medicare Advantage payment formulations, and specifies that a certain percentage of corresponding payment increases must be directed toward payments for basic benefits.